Nathan Dau - Profile and Investment Details

Investor Profile

Nathan Dau is a Venture Capital, Private Equity Firm, Investor based in United States with a diverse investment portfolio that includes companies such as Ossium Health, Aligos Therapeutics, Olema Oncology, Synapse Biomedical, Sinovac Biotech, Visen Pharmaceuticals, IO Biotech, IGM Biosciences, Nabriva Therapeutics, Metacrine, Design Therapeutics, Kira Pharmaceuticals, Cerebral Therapeutics, Medeor Therapeutics, Tarsus Pharmaceuticals, Ascendis Pharma, Serán Bioscience, Innocare, Fortis Therapeutics, Tranquis Therapeutics, SentreHEART, Homology Medicines, Verona Pharma, Bolt Biotherapeutics, Legend Biotech, ASLAN Pharmaceuticals, Citrine Medicine, BlossomHill Therapeutics, ReadCoor, Nora Therapeutics, Immune-Onc Therapeutics, dMed, Akari Therapeutics, Outpost Medicine, Precision BioSciences, Tricida, Crinetics Pharmaceuticals, Harmony Biosciences, Terns Pharmaceuticals, Sierra Oncology, Ventyx Biosciences, Elevation Oncology, MacuLogix, ALX Oncology, TOT BIOPHARM, Impel NeuroPharma, Gracell Biotechnologies, Aclaris Therapeutics, Apellis Pharmaceuticals, Biohaven Pharmaceutical, Amyris, Rongchang Pharmaceutical, Remegen, Gengmei, Celladon, REGENXBIO, PatientPop, Passage Bio, Angiotech Pharmaceuticals, Preventice Solutions, Poseida Therapeutics, Provivi, VYNE Therapeutics, MEI Pharma, Coherus Biosciences, Satsuma Pharmaceuticals, AirXpanders, Genetron Health, Bristol-Myers Squibb, INBRACE, Revolution Medicines, Platelet BioGenesis, Kadmon, Aadi Bioscience, Neocis, Kala Pharmaceuticals, Mereo Biopharma, Arcutis Biotherapeutics, Zai Lab. Over time, Nathan Dau has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Nathan Dau is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Hospitals, Women Founded, Robotics, Biotech, Medical Device, Healthcare, Biotechnology, Health and Hospital Services, Health IT, Digital Health, Medical, Therapeutics, Pharmaceuticals, Biopharma may find it worthwhile to explore potential connections with Nathan Dau, as their portfolio suggests a familiarity and interest in this area.

Understanding Nathan Dau’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.